首页> 美国卫生研究院文献>Springer Open Choice >The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma
【2h】

The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma

机译:组织病理学和NAB2-STAT6融合亚型对脑膜孤立性纤维瘤/血运细胞瘤的分类和分级的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Meningeal solitary fibrous tumor (SFT)/hemangiopericytoma (HPC) is a rare tumor with propensity for recurrence and metastasis. Although multiple classification schemes have been proposed, optimal risk stratification remains unclear, and the prognostic impact of fusion status is uncertain. We compared the 2016 WHO CNS tumor grading scheme (CNS-G), a three-tier system based on histopathologic phenotype and mitotic count, to the 2013 WHO soft-tissue counterpart (ST-G), a two-tier system based on mitotic count alone, in a cohort of 133 patients [59 female, 74 male; mean age 54 years (range 20–87)] with meningeal SFT/HPC. Tumors were pathologically confirmed through review of the first tumor resection (n = 97), local recurrence (n = 35), or distant metastasis (n = 1). A STAT6 immunostain showed nuclear expression in 132 cases. NAB2–STAT6 fusion was detected in 99 of 111 successfully tested tumors (89%) including the single STAT6 immunonegative tumor. Tumors were classified by CNS-G as grade 1 (n = 43), 2 (n = 41), or 3 (n = 49), and by ST-G as SFT (n = 84) or malignant SFT (n = 49). Necrosis was present in 16 cases (12%). On follow-up, 42 patients had at least one subsequent recurrence or metastasis (7 metastasis only, 33 recurrence only, 2 patients had both). Twenty-nine patients died. On univariate analysis, necrosis (p = 0.002), CNS-G (p = 0.01), and ST-G (p = 0.004) were associated with recurrence-free (RFS) but not overall survival (OS). NAB2–STAT6 fusion type was not significantly associated with RFS or OS, but was associated with phenotype. A modified ST-G incorporating necrosis showed higher correlation with RFS (p = 0.0006) and remained significant (p = 0.02) when considering only the primary tumors. From our data, mitotic rate and necrosis appear to stratify this family of tumors most accurately and could be incorporated in a future grading scheme.Electronic supplementary materialThe online version of this article (10.1007/s00401-018-1952-6) contains supplementary material, which is available to authorized users.
机译:脑膜孤立性纤维性肿瘤(SFT)/血管内皮细胞瘤(HPC)是一种罕见的肿瘤,易复发和转移。尽管已经提出了多种分类方案,但最佳风险分层仍然不清楚,融合状态的预后影响尚不确定。我们将2016 WHO WHO CNS肿瘤分级方案(CNS-G)(基于组织病理学表型和有丝分裂计数的三层系统)与2013 WHO WHO软组织对应物(ST-G)(基于有丝分裂的两层系统)进行了比较在133例患者中单独计数[女性59例,男性74例;平均年龄54岁(范围20-87)],伴有脑膜SFT / HPC。通过第一次肿瘤切除(n = 97),局部复发(n = 35)或远处转移(n = 1)进行病理学确认。 STAT6免疫染色在132例中显示出核表达。在包括单个STAT6免疫阴性肿瘤在内的111个成功测试的肿瘤中,有99个(占89%)检测到NAB2-STAT6融合。 CNS-G将肿瘤分为1级(n = 43),2(n = 41)或3级(n = 49),ST-G将其分为SFT(n = 84)或恶性SFT(n = 49)。 )。 16例(12%)出现坏死。随访时,有42例患者至少有1次随后复发或转移(仅7例转移,仅33例复发,2例均同时复发)。二十九名患者死亡。单因素分析显示,坏死(p = 0.002),CNS-G(p = 0.01)和ST-G(p = 0.004)与无复发(RFS)相关,但与总生存期(OS)不相关。 NAB2-STAT6融合类型与RFS或OS无关,但与表型有关。仅考虑原发性肿瘤时,一种融合了坏死的改良ST-G与RFS的相关性较高(p = 0.0006),并且仍显着( p = 0.02)。从我们的数据来看,有丝分裂率和坏死似乎可以最准确地将这一家族肿瘤分层,并且可以纳入未来的分级方案中。电子补充材料本文的在线版本(10.1007 / s00401-018-1952-6)包含补充材料,可供授权用户使用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号